3 ms·
Anti-periodontic diseases are highly irrelevant compared to cavities. Not even the original cavity application did manage to get enough funding at the time. So
by cubefox 6mo ago
Anti-periodontic diseases are highly irrelevant compared to cavities. Not even the original cavity application did manage to get enough funding at the time. So there will be no Indian upstart, there is and likely will be nobody who invests the money into ultra expensive trials. The ship has sailed.
- fakedang 6mo agoI wasn't trying to quote a directly applicable example, just wanted to illustrate a potential pathway for post-expiry commercialization.